Navigation Links
PAREXEL International Reports Third Quarter Fiscal Year 2013 Results

on for income tax expense$




3,887Net income$
9,862Diluted earnings per common share$
.33Effective tax rate17.6%19.6%-4.2%16.4%Explanatory Note:(a) Adjustment includes $1.1 million in legal charges related to disputes and $0.3 million in integration charges related to the acquisition of Liquent, Inc.(b) Decrease in facility-related charges of $0.7 million related to restructuring plans(c) Accelerated amortization of deferred financing fees related to credit facility modification(d) Tax associated with items (a) through (c), and a $0.5 million adjustment due to state valuation allowance release(e) Restructuring charges include $2.0 million in severance costs offset by a $0.2 million decrease in facilities-related charges(f) Tax associated with (e) and a $4.2 million benefit in Q3 FY12 due to the favorable conclusion of a tax examination and expiration of statutory periods, primarily in European  jurisdictions.  

 PAREXEL International Corporation  Reconciliation of Non-GAAP MeasuresCertain Line Items(Unaudited)Nine Months EndedNine Months Ended(in thousands, except per share data)March 31, 2013March 31, 2012GAAP MeasureAdjustmentsNon-GAAP MeasureGAAP MeasureAdjustmentsNon-GAAP MeasureSelling, general and administrative $   229,975$


92,506Restructuring (benefit) charge$




-Income from operations$
8,932Other expense, net$


(8,445)Income before income taxes$

SOURCE PAREXEL International Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
2. PAREXEL International to Present at J.P. Morgan Healthcare Conference
3. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
4. PAREXEL and ASAN Medical Center Establish Alliance to Accelerate Korea-based Drug Development and Commercialization Programs
5. PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium
6. PAREXEL International To Present At Goldman Sachs Healthcare Conference And Jefferies Healthcare Conference
7. PAREXEL International Reports First Quarter Fiscal Year 2013 Results
8. PAREXEL International to Present at Morningstar Conference
9. PAREXEL Announces Date of Third Quarter Fiscal Year 2013 Earnings Release and Conference Call
10. UV Flu Technologies Expands Its International Footprint
11. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
Post Your Comments:
(Date:8/28/2014)... in spintronics, an electronic which is not only ... on their spin and the spin-related magnetism. Spin-charge ... signals and vice versa. Recently, the research group ... Physics at Johannes Gutenberg University Mainz in collaboration ... has for the first time realised a new, ...
(Date:8/28/2014)... 2014  Next month, executives from clinical trial marketing firm ... beginning with Patient-Centered Clinical Trials 2014 , to be ... , September 4-5. Patient recruitment experts Bonnie A. ... will share insights on the benefits of employing an ... – from media to mobile apps – can be used ...
(Date:8/28/2014)... PARK, Calif. , Aug. 28, 2014 /PRNewswire/ ... focused on developing novel mid- to late-stage cardiovascular ... $7.0 million in its first round of financing. ... Biomedical Investments and Hercules Bioventures with participation from ... entrepreneur and pharmaceutical executive, Dr. Larry Hsu ...
(Date:8/28/2014)... A new market research report ... available from Strategic Consulting, Inc., the leading information ... Market Review, Fourth Edition: Global Review of Microbiology ... and compares microbiology test volumes, market values and ... Asia, and forecasts future volumes and market values ...
Breaking Biology Technology:A new, tunable device for spintronics 2A new, tunable device for spintronics 3BBK Worldwide Leads Sessions at Key September Events 2Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 32 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3
... April 14 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), ... (MS), today announced that the independent Data Safety Monitoring ... MAESTRO-03 trial of dirucotide in patients with secondary progressive ... the trial continue as per the protocol. , This ...
... Calif., April 14 Zenobia Therapeutics, Inc., the ... the central nervous system, announced successful completion of ... Syntonix Pharmaceuticals, a wholly-owned subsidiary of Biogen Idec ... the agreement, Syntonix gains access to Zenobia,s technology ...
... Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) provides ... 2009 third quarter and nine-month period ended February 28, ... fiscal year 2009 now ending on February, 28. , ... February 28, 2009 in the range of $3,400,000 to ...
Cached Biology Technology:BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2Zenobia Therapeutics Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals 2Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 2Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 3Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 4Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 5
(Date:8/29/2014)... fold them: modern materials that are light, flexible and ... skin or electronic paper. , Making such concepts affordable ... new way of working with copper nanowires and a ... Previous success in the field of ultra-lightweight "aerogel monoliths" ... and silver nanowires. , By turning instead to ...
(Date:8/28/2014)... called TX Invasives is now available from the Lady ... at Austin for identifying harmful non-native plant, insect and ... the United States cause about $137 billion in economic ... clog waterways, kill native plants and more. , "By ... reporting where invasive species occur, we,re more likely to ...
(Date:8/28/2014)... University researchers have identified a handful of bacterial culprits ... Crohn,s disease and ulcerative colitis, using patients, own intestinal ... published Aug. 28 in the journal Cell . ... microbiota, which plays a critical role in the development ... a small number of bacterial species affect a person,s ...
Breaking Biology News(10 mins):Copper shines as flexible conductor 2Mobile app makes ID of harmful plants, insects in Texas a snap 2Yale study identifies possible bacterial drivers of IBD 2
... blanket to stave off the shivers? A new study ... in patients who have been cooled to prevent brain ... fevers are often cooled to reduce their core body ... cooling induces a natural and familiar response - shivering. ...
... COLUMBUS, Ohio A study comparing how two common ... oils, by themselves, can lower body fat in obese ... oils compared were safflower oil, a common cooking oil, ... in some meat and dairy products that has been ...
... unexpected role of iron in regulating biological production ... important implications for our understanding of ocean-climate interactions. ... production in the sunlit surface waters of the ... sequester large amounts of atmospheric carbon dioxide. ...
Cached Biology News:Two dietary oils, two sets of benefits for older women with diabetes 2Two dietary oils, two sets of benefits for older women with diabetes 3Two dietary oils, two sets of benefits for older women with diabetes 4Iron and biological production in the high-latitude North Atlantic 2Iron and biological production in the high-latitude North Atlantic 3
... Fingerprinting II Informatix ... an optional module ... component analysis, multidimensional ... and MANOVA, and ...
Fingerprinting II Informatix optional matrix types module, is an optional module that adds external similarity and distance matrix functions to the Fingerprinting II Informatix software package....
... is a completely redesigned and updated version ... accepts the full line of well-proven Alpha ... in thermal performance as the DNA Engine ... easy transport of protocols among platforms. ...
... Ideal for hand-held applications or for ... II with a hand-held eight-port disposable manifold ... than a multi-channel pipette. The StatMatic II ... bottle sizes and can completely fill a ...
Biology Products: